Tolerability, pharmacokinetics and pharmacodynamics of ascending single and repeated doses of SAR444336 in healthy adult participants

Trial Identifier: TDU17072
Sponsor: Sanofi
Start Date: October 2021
Study Completion Date: February 2023
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
NETHERLANDS NETHERLANDS